Liberty Expedia Holdings (LEXEB:NAS) and Cidara Therapeutics (CDTX:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEXEB Liberty Expedia Holdings Inc 43.180000 57326415 None 1.0310 43.82 -30.20
SOHU Sohu.com Ltd 17.260000 38916788 None 1.1407 21.06 9.12
FTR Frontier Communications Corp 2.510000 105318646 None 0.1652 3.36 -159.69
TA TravelCenters of America LLC 4.340000 40397551 None 0.3906 7.78 -9.95
APTX Aptinyx Inc 4.130000 33562211 None 0.9283 4.49 None
MGI MoneyGram International Inc 2.420000 56386051 None None 2.58 -13.40
CDTX Cidara Therapeutics Inc 2.700000 26616014 None 1.2152 2.80 2.43
AQXP Aquinox Pharmaceuticals Inc 2.630000 23537368 None 0.8518 3.27 3.27
SORL SORL Auto Parts Inc 3.170000 19304921 4.8030 0.3464 3.81 -9.32
SCPH scPharmaceuticals Inc 2.930000 18580430 None 0.6914 4.82 4.30
INNT Innovate Biopharmaceuticals Inc 1.790000 30269888 None 169.7917 189.26 17.58
MLNT Melinta Therapeutics Inc 4.290000 11229897 None 0.2535 7.28 -2.55
SHOS Sears Hometown and Outlet Stores Inc 1.900000 22702132 None 0.3596 1.90 -4.52
APWC Asia Pacific Wire & Cable Corp Ltd 2.290000 13819669 4.9783 0.2086 3.52 1.27
GEVO Gevo Inc 2.440000 11658387 None 0.3204 2.89 1.82
GIGM GigaMedia Ltd 2.529600 11052235 28.0000 0.4806 5.42 5.77
ADXS Advaxis Inc 3.850000 5506984 None 0.5654 5.94 20.47
TNXP Tonix Pharmaceuticals Holding Corp 2.710000 6089728 None 0.6974 4.11 0.29
BIQI Renmin Tianli Group Inc 1.980200 8033745 None 0.1820 7.64 7.39
TENX Tenax Therapeutics Inc 1.910000 6154434 None 0.9986 2.01 0.83
CLRB Cellectar Biosciences Inc 2.470000 4757709 None 1.0947 2.79 2.79
KBSF KBS Fashion Group Ltd 4.120000 2228497 None 0.1338 9.07 8.58
ABIO ARCA biopharma Inc 5.710000 1019736 None 0.9653 6.48 7.61
CHFS CHF Solutions Inc 4.270000 968623 None 0.6968 5.66 1.37
JMU JMU Ltd 2.130000 819615 None 0.0859 12.09 3.21

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

LEXEB:NAS Liberty Expedia Holdings

http://www.libertyexpedia.com
Liberty Expedia Holdings has 24500 employees and is headquartered in United States.
Liberty Expedia Holdings Inc is an online travel company. It operates a strong brand portfolio with global reach, targeting a broad range of travelers, travel suppliers, and advertisers.

CDTX:NAS Cidara Therapeutics

http://www.cidara.com
Cidara Therapeutics has 68 employees and is headquartered in United States.
Cidara Therapeutics Inc mainly develops anti-infective drugs in the United States. It attends to serious fungal infections through its drug candidates and proprietary immunotherapy technology platform, Cloudbreak.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.